Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-464-972"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20121023.45.2-464-972"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"The European Medicines Agency provides the EU Member States and EU institutions with scientific advice on questions relating to the evaluation of the quality, safety and effectiveness of medicinal products for human and veterinary use. It is therefore extremely important to avoid a conflict of interests. However, in June 2012, a ‘revolving door’ case occurred at the Agency, the consequences of which are still unknown pending the outcome of the investigation. I therefore voted against this report."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples